Bank Of New York Mellon Corp Syndax Pharmaceuticals Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $3.97 Million - $5.05 Million	192,483 New	192,483 $4.9 Million
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $407,349 - $545,553	22,007 Added 13.16%	189,194 $4.55 Million
Q2 2022 Aug 15, 2022	SELL	$13.64 - $19.48 $125,542 - $179,293	-9,204 Reduced 5.22%	167,187 $3.22 Million
Q1 2022 May 11, 2022	BUY	$14.84 - $22.15 $145,713 - $217,490	9,819 Added 5.89%	176,391 $3.07 Million
Q4 2021 Feb 11, 2022	SELL	$15.23 - $22.47 $27,078 - $39,951	-1,778 Reduced 1.06%	166,572 $3.65 Million
Q3 2021 Nov 12, 2021	BUY	$13.87 - $19.8 $296,887 - $423,819	21,405 Added 14.57%	168,350 $3.22 Million
Q2 2021 Aug 11, 2021	BUY	$13.42 - $25.18 $220,490 - $413,707	16,430 Added 12.59%	146,945 $2.52 Million
Q4 2020 Feb 09, 2021	BUY	$15.1 - $26.44 $407,035 - $712,716	26,956 Added 26.03%	130,515 $2.9 Million
Q3 2020 Nov 12, 2020	BUY	$13.39 - $17.48 $241 - $314	18 Added 0.02%	103,559 $1.53 Million
Q2 2020 Aug 12, 2020	BUY	$8.94 - $20.98 $187,015 - $438,880	20,919 Added 25.32%	103,541 $1.53 Million
Q1 2020 May 06, 2020	BUY	$6.65 - $12.03 $50,772 - $91,849	7,635 Added 10.18%	82,622 $906,000
Q4 2019 Feb 14, 2020	BUY	$5.43 - $9.22 $14,346 - $24,359	2,642 Added 3.65%	74,987 $658,000
Q3 2019 Nov 07, 2019	BUY	$7.47 - $10.76 $10,801 - $15,558	1,446 Added 2.04%	72,345 $540,000
Q2 2019 Aug 12, 2019	BUY	$4.9 - $9.31 $23,701 - $45,032	4,837 Added 7.32%	70,899 $659,000
Q1 2019 May 14, 2019	BUY	$4.26 - $6.86 $4,370 - $7,038	1,026 Added 1.58%	66,062 $347,000
Q4 2018 Feb 11, 2019	BUY	$3.6 - $8.42 $54,986 - $128,607	15,274 Added 30.69%	65,036 $289,000
Q3 2018 Nov 09, 2018	SELL	$6.33 - $8.08 $193,761 - $247,328	-30,610 Reduced 38.09%	49,762 $0
Q2 2018 Aug 06, 2018	BUY	$6.93 - $14.63 $234,871 - $495,839	33,892 Added 72.92%	80,372 $564,000
Q1 2018 May 15, 2018	BUY	$8.71 - $14.82 $11,357 - $19,325	1,304 Added 2.89%	46,480 $661,000
Q4 2017 Feb 09, 2018	BUY	$7.8 - $12.94 $352,372 - $584,577	45,176	45,176 $396,000

Others Institutions Holding SNDX

# of Institutions

227

Shares Held

88.3M

Call Options Held

1.01M

Put Options Held

692K

Black Rock Inc. New York, NY

7.91M
Shares

$127 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

5.84M
Shares

$94 Million
9.23% of portfolio
Wellington Management Group LLP Boston, MA

4.99M
Shares

$80.2 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

4.89M
Shares

$78.6 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

4.11M
Shares

$66.1 Million
6.25% of portfolio

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $910M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account